
P3 Health Partners Inc. (($PIII)) has held its Q3 earnings call. Read on for the main highlights of the call. P3 Health Partners delivered a strongly positive earnings call, highlighting
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| PIII | P3 Health Partners | 1.86 | -3.22 | -63.37% |
| Name | Price | % Change | |
|---|---|---|---|
| $1.86 | -63.37% |

P3 Health Partners Inc. (($PIII)) has held its Q3 earnings call. Read on for the main highlights of the call. P3 Health Partners delivered a strongly positive earnings call, highlighting

TD Cowen lowered the firm’s price target on P3 Health Partners (PIII) to $4 from $13 and keeps a Hold rating on the shares. The firm updated its model following

P3 Health Partners Inc. (PIII) has disclosed a new risk, in the Regulation category. Nasdaq listing compliance emerges as a key risk, as P3 Health Partners Inc. relied on a

Reports Q3 revenue $396M, two estimates $385.15M. “This was another strong quarter for P3. The foundation we have built over the past two years is showing up both in the

Two estimates $1.55B. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on PIII:

Lake Street lowered the firm’s price target on P3 Health Partners (PIII) to $11.50 from $23 and keeps a Buy rating on the shares, citing reduced FY27 aEBITDA expectations and

P3 Health Partners Inc. (PIII) is scheduled to report 3rd quarter earnings on 11/09/2026, after the market closes. Regarding Q3 estimates, Wall Street analysts expect P3 Health Partners Inc. to

This filing relates to the offer and sale from time to time by the selling stockholders of up to 15.64M shares of Class A common stock. The company is not

P3 Health Partners (PIII) announced the appointment of Dr. Michael Millie as Chief Clinical Officer, effective October 12, 2026. Dr. Millie most recently served as a Chief Medical Officer, overseeing

P3 Health Partners ( ($PIII) ) has issued an update. On September 8, 2026, P3 Health Partners entered into a Securities Purchase Agreement with affiliates of Chicago Pacific Founders to
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| Apr 1, 2027TBA | $15.61M | $-4.79 | $404.40M | 0.02 | -0.09 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.